U.S. Markets closed

  • S&P 500

    4,401.46
    -20.84 (-0.47%)
     

  • Dow 30

    35,058.52
    -85.79 (-0.24%)
     

  • Nasdaq

    14,660.58
    -180.14 (-1.21%)
     

  • Russell 2000

    2,191.83
    -25.09 (-1.13%)
     

  • Crude Oil

    71.94
    +0.29 (+0.40%)
     

  • Gold

    1,799.00
    -0.80 (-0.04%)
     

  • Silver

    24.73
    +0.08 (+0.31%)
     

  • EUR/USD

    1.1826
    0.0000 (-0.00%)
     

  • 10-Yr Bond

    1.2340
    -0.0420 (-3.29%)
     

  • GBP/USD

    1.3878
    -0.0001 (-0.01%)
     

  • USD/JPY

    109.7730
    +0.0060 (+0.01%)
     

  • BTC-USD

    39,092.03
    +1,451.18 (+3.86%)
     

  • CMC Crypto 200

    898.78
    +22.55 (+2.57%)
     

  • FTSE 100

    6,996.08
    -29.35 (-0.42%)
     

  • Nikkei 225

    27,970.22
    +136.93 (+0.49%)
     

Top Ranked Momentum Stocks to Buy for April 22nd

Zacks Equity Research
·2 min read

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 22nd:

Ardmore Shipping Corporation (ASC): This company engaged in the seaborne transportation of petroleum products and chemicals has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 32.5% over the last 60 days.

Ardmore Shipping Corporation Price and Consensus

Ardmore Shipping Corporation Price and Consensus
Ardmore Shipping Corporation Price and Consensus

Ardmore Shipping Corporation price-consensus-chart | Ardmore Shipping Corporation Quote

Ardmore Shipping’s shares gained 45.7% over the last one month above the S&P 500’s increase of 21.3%. The company possesses a Momentum Score of B.

Ardmore Shipping Corporation Price

Ardmore Shipping Corporation Price
Ardmore Shipping Corporation Price

Ardmore Shipping Corporation price | Ardmore Shipping Corporation Quote

CorMedix, Inc. (CRMD): This biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.9% over the last 60 days.

CorMedix Inc Price and Consensus

CorMedix Inc Price and Consensus
CorMedix Inc Price and Consensus

CorMedix Inc price-consensus-chart | CorMedix Inc Quote

CorMedix’s shares gained 48.5% over the last one month. The company possesses a Momentum Score of B.

CorMedix Inc Price

CorMedix Inc Price
CorMedix Inc Price

CorMedix Inc price | CorMedix Inc Quote

Arcimoto, Inc. (FUV): This manufacturer of three-wheeled electric vehicles has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 26.1% over the last 60 days.

Arcimoto, Inc. Price and Consensus

Arcimoto, Inc. Price and Consensus
Arcimoto, Inc. Price and Consensus

Arcimoto, Inc. price-consensus-chart | Arcimoto, Inc. Quote

Arcimoto’s shares gained 27.6% over the last one month. The company possesses a Momentum Score of B.

Arcimoto, Inc. Price

Arcimoto, Inc. Price
Arcimoto, Inc. Price

Arcimoto, Inc. price | Arcimoto, Inc. Quote

Ovid Therapeutics Inc. (OVID): This biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 25.4% over the last 60 days.

OVID THERAPEUTC Price and Consensus

OVID THERAPEUTC Price and Consensus
OVID THERAPEUTC Price and Consensus

OVID THERAPEUTC price-consensus-chart | OVID THERAPEUTC Quote

Ovid Therapeutics’ shares gained 38.9% over the last one month. The company possesses a Momentum Score of B.

OVID THERAPEUTC Price

OVID THERAPEUTC Price
OVID THERAPEUTC Price

OVID THERAPEUTC price | OVID THERAPEUTC Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>                  


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
OVID THERAPEUTC (OVID) : Free Stock Analysis Report
 
Arcimoto, Inc. (FUV) : Free Stock Analysis Report
 
CorMedix Inc (CRMD) : Free Stock Analysis Report
 
Ardmore Shipping Corporation (ASC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.

Recommended Stories

  • Apple earnings: Huge iPhone 12 sales beat analyst expectations

    Apple beat analyst expectations for its Q3 earnings thanks to the performance of its iPhone 12.

  • Why Novavax Stock Is Sliding Today

    Shares of Novavax (NASDAQ: NVAX) were sliding 6.7% lower as of 11:14 a.m. EDT on Tuesday. The decline came after the Australian newspaper The Guardian reported major delays with Australia's supply deal for Novavax's COVID-19 vaccine, NVX-CoV2373. Novavax signed an agreement in January 2021 to supply 51 million doses of its COVID vaccine to Australia.

  • Why Teladoc Health Stock Is Diving in After-Hours Trading Today

    This earnings season isn't shaping up to be a merry one for coronavirus stock Teladoc Health (NYSE: TDOC) following the release of its latest earnings after the market close Tuesday. For its second quarter, Teladoc managed to grow its top line by 109% to $503 million, fueled by 138% growth in the company's access fees (which accounted for 86% of total revenue). More than a little of this was due to expenses related to the large-scale acquisition of healthcare sector peer Livongo Health.

  • Cassava Looks to Extend Breakneck Rally on Alzheimer’s Data

    (Bloomberg) -- Another double-digit share price rally could be in store for Cassava Sciences Inc. over the next month, as the biotech vies with retail trading favorites AMC Entertainment Holdings Inc. and GameStop Corp. to be the year’s top-performing stock in the Russell 3000.In the run-up to the big reveal from a mid-stage study, the 23-year old drug developer has sprinted more than 1,700% this year. On July 29, Cassava is expected to present safety and cognition data from about 50 people with

  • Apple reports earnings after the bell on Tuesday — here’s what to expect

    Cowen Analyst, Krish Sankar, joins Yahoo Finance to discuss what to expect from Apple ahead of the company reporting earnings and the possible effect the release of a new iPhone can have on its stock moving forward.

  • Analyst breaks down Microsoft's Q3 earnings beat

    Peter Hanks, an anlyst at DailyFX, analyzes what Microsoft's earnings beat means for the future of the stock. 

  • Why Tilray, Sundial Growers, and Other Cannabis Stocks Dropped Today

    As talk of potential legislation to legalize cannabis in the U.S. continues, stocks of many Canadian growers have been volatile. In just the past month, shares of Tilray (NASDAQ: TLRY), Sundial Growers (NASDAQ: SNDL), and OrganiGram Holdings (NASDAQ: OGI) are down 30%, 20%, and 18%, respectively. Tilray CEO Irwin Simon did give an interview yesterday in which he discussed the future of the company and explained its position in preparation for potential U.S. legalization.

  • Is It Too Late to Buy Nio Stock?

    Shares of Chinese electric-vehicle (EV) maker Nio (NYSE: NIO) are about 30% below January 2021 highs. Nio ES8 electric SUVs being loaded for transit to Norway. Nio has been quickly growing sales of its EVs.

  • Microsoft earnings: Cloud and personal computing growth power earnings beat

    Microsoft beat analyst expectations for its Q4 earnings, thanks to strength from its cloud and productivity segments.

  • Why Activision Blizzard Is Tumbling Today

    Shares of Activision Blizzard (NASDAQ: ATVI) were tumbling 7.7% in midday trading Tuesday as allegations of a hostile work environment embroil the video game company. Work on updates to the massively popular World of Warcraft franchise was also reportedly put on hold as the company responds to a lawsuit over the charges of misconduct. Activision was sued by the California Department of Fair Employment and Housing over a reported "pervasive frat boy workplace culture" that led to charges of harassment and unequal pay.

  • Why SkyWater Technology Stock Got Destroyed Today

    The semiconductor company reported disappointing preliminary results but is preparing to invest in manufacturing capacity.

  • Ovintiv Reports Second Quarter 2021 Financial and Operating Results

    Ovintiv Inc. (NYSE: OVV) (TSX: OVV) today announced its second quarter 2021 financial and operating results. In addition, the Company increased its quarterly dividend payment by approximately 50%, accelerated its $4.5 billion net debt target timeline to the end of 2021 and set a new net debt target of $3 billion by year-end 2023, assuming $50 per bbl WTI oil and $2.75 per Mcf NYMEX natural gas prices.

  • Why UPS Stock's Tuesday Crash Makes No Sense

    Record revenue and cash flows, a stronger balance sheet, solid outlook -- what else do you want from UPS?

  • I’m retiring on my 78th birthday, have more than $200,000 in savings and share expenses with my 80-year-old boyfriend. Will I be OK?

    See: We have $8 million saved for retirement, are in our early 50s and want to retire early, but are worried about healthcare expenses — what can we do? Before you get discouraged or angry, know that there are many, many variables that go into determining if one will be secure in retirement. It’s also important to note that anything can change, and even people who have amassed a million dollars or more for retirement could find themselves in a predicament that forces them to go back to work or adjust their spending.

  • Cassava: Alzheimer’s Diagnostic Test Could Add Another Feather to the Cap

    Cassava Sciences (SAVA) shares have been on an almighty rampage in 2021, up by a huge 1,736% year-to-date. Those gains are down to the potential of simufilam, the company’s Alzheimer’s disease (AD) candidate for which clinical trial results have so far impressed all and sundry. However, on Monday, at the Alzheimer’s Association International Conference (AAIC), Cassava presented positive clinical data pertaining to not only simufilam but to its other offering SavaDX, an investigational diagnostic

  • Chipmaker AMD Clears Wall Street's Second-Quarter Hurdles

    Chipmaker Advanced Micro Devices late Tuesday topped analyst expectations for the second quarter and guided higher.

  • The Science Behind Jon Rahm’s Covid-19 Déjà Vu

    Jon Rahm tested positive for Covid again—after getting vaccinated. Here’s what that could mean for the rest of us.

  • Better Buy: Sea Limited vs. Coupang

    Sea Limited (NYSE: SE) and Coupang (NYSE: CPNG) are two of the fastest growing e-commerce companies in Asia. Sea owns Shopee, the largest e-commerce platform in Southeast Asia and Taiwan, while Coupang owns the largest online marketplace in South Korea. The market has been much kinder to Sea than Coupang.

  • Microsoft Stock Is Falling Despite Strong Earnings

    Microsoft's revenue rose 21% in its latest quarter, which was more than analysts expected. Investors were hoping for an even bigger beat.

  • UPS shares slide, JetBlue sees bounce back, upbeat GE free cash flow outlook, Chinese-based stocks continue decline

    Yahoo Finance’s Ines Ferre reports on the day's trending tickers.